Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 satta2018design
%A Satta, Alessandro
%A Mezzanzanica, Delia
%A Caroli, Francesco
%A Frigerio, Barbara
%A Di Nicola, Massimo
%A Kontermann, Roland E.
%A Iacovelli, Federico
%A Desideri, Alessandro
%A Anichini, Andrea
%A Canevari, Silvana
%A Gianni, Alessandro Massimo
%A Figini, Mariangela
%D 2018
%I Taylor & Francis
%J mAbs
%K
%N 7
%P 1084-1097
%R 10.1080/19420862.2018.1494105
%T Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells
%V 10
@article{satta2018design,
added-at = {2023-08-31T16:49:29.000+0200},
affiliation = {Satta, A; Figini, M (Reprint Author), Via Amadeo 42, I-20133 Milan, Italy.
Satta, Alessandro; Mezzanzanica, Delia; Caroli, Francesco; Frigerio, Barbara; Canevari, Silvana; Figini, Mariangela, Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Therapies Unit, Milan, Italy.
Di Nicola, Massimo; Gianni, Alessandro Massimo, Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol & Hematol, Med Oncol Unit C, Milan, Italy.
Kontermann, Roland E., Univ Stuttgart, Inst Zellbiol & Immunol, Stuttgart, Germany.
Iacovelli, Federico; Desideri, Alessandro, Univ Roma Tor Vergata, Dept Biol, Rome, Italy.
Anichini, Andrea, Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Human Tumor Immunobiol Unit, Milan, Italy.
Gianni, Alessandro Massimo, Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.
Satta, Alessandro; Frigerio, Barbara; Figini, Mariangela, Fdn IRCCS Ist Nazl Tumori, DRAST, Biomarkers Unit, Milan, Italy.
Caroli, Francesco, ASST Grande Osped Metropolitano Niguarda, Dept Lab Med, Chem Clin Anal Area, Milan, Italy.
Di Nicola, Massimo, Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol & Hematol, Clin Immunotherapy Tumors & Innovat Therapies Uni, Milan, Italy.
Mezzanzanica, Delia, Fdn IRCCS Ist Nazl Tumori, DREaMM, Mol Therapies Unit, Milan, Italy.
Gianni, Alessandro Massimo, Ist Europeo Oncol, Dept Hematol, Milan, Italy.
Gianni, Alessandro Massimo, Univ Milan, Milan, Italy.},
author = {Satta, Alessandro and Mezzanzanica, Delia and Caroli, Francesco and Frigerio, Barbara and Di Nicola, Massimo and Kontermann, Roland E. and Iacovelli, Federico and Desideri, Alessandro and Anichini, Andrea and Canevari, Silvana and Gianni, Alessandro Massimo and Figini, Mariangela},
biburl = {https://puma.ub.uni-stuttgart.de/bibtex/2db1b132dd5c706568a7485d4e461ac30/puma-wartung},
doi = {10.1080/19420862.2018.1494105},
interhash = {c2fd9b7b5e4cb2bd15c0de6a7d8586ec},
intrahash = {db1b132dd5c706568a7485d4e461ac30},
issn = {{1942-0862} and {1942-0870}},
journal = {mAbs},
keywords = {},
language = {eng},
number = 7,
orcid-numbers = {Canevari, Silvana/0000-0002-2963-3587
Satta, Alessandro/0000-0002-3717-9337
Mezzanzanica, Delia/0000-0002-9664-6871
Iacovelli, Federico/0000-0001-7511-6575},
pages = {1084-1097},
publisher = {Taylor & Francis},
research-areas = {Research & Experimental Medicine},
researcherid-numbers = {Satta, Alessandro/Q-3504-2019
Mezzanzanica, Delia/C-2607-2017},
timestamp = {2023-08-31T14:49:29.000+0200},
title = {Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells},
unique-id = {ISI:000445653300013},
volume = 10,
year = 2018
}